These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2311125)
1. A novel guanosine analog, 7-thia-8-oxoguanosine, enhances macrophage and lymphocyte antibody-dependent cell-mediated cytotoxicity. Jin A; Mhaskar S; Jolley WB; Robins RK; Ojo-Amaize EA Cell Immunol; 1990 Apr; 126(2):414-9. PubMed ID: 2311125 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice. Sharma BS; Mhaskar S; Balazs L; Siaw M Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine. II. Characterization of induced effector cells and the mechanism of induction. Sharma BS; Mhaskar S; Balazs L; Jin A; Smee DF Immunopharmacol Immunotoxicol; 1992; 14(1-2):21-38. PubMed ID: 1375956 [TBL] [Abstract][Full Text] [Related]
4. Roles of interferon and natural killer cells in the antiviral activity of 7-thia-8-oxoguanosine against Semliki Forest virus infections in mice. Smee DF; Alaghamandan HA; Jin A; Sharma BS; Jolley WB Antiviral Res; 1990 Feb; 13(2):91-102. PubMed ID: 1693058 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of phosphoinositide signaling pathway in murine B lymphocytes by a novel guanosine analog, 7-thia-8-oxoguanosine. Parandoosh Z; Ojo-Amaize E; Robins RK; Jolley WB; Rubalcava B Biochem Biophys Res Commun; 1989 Sep; 163(3):1306-11. PubMed ID: 2551285 [TBL] [Abstract][Full Text] [Related]
7. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action. Colic M; Vucevic D; Vasilijic S; Popovic L; Pejanovic V; Jandric D; Medic-Mijacevic L; Rakic L Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):583-90. PubMed ID: 10669901 [TBL] [Abstract][Full Text] [Related]
8. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines. Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754 [TBL] [Abstract][Full Text] [Related]
9. Modulatory effect of 7-thia-8-oxoguanosine on proliferation of rat thymocytes in vitro stimulated with concanavalin A. Colić M; Gasić S; Vucević D; Pavicić L; Popović P; Jandrić D; Medić-Mijacević L; Rakić L Int J Immunopharmacol; 2000 Mar; 22(3):203-12. PubMed ID: 10685003 [TBL] [Abstract][Full Text] [Related]
10. In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine). Pope BL; Chourmouzis E; Sigindere J; Capetola RJ; Lau CY Int J Immunopharmacol; 1992 Nov; 14(8):1375-82. PubMed ID: 1464469 [TBL] [Abstract][Full Text] [Related]
11. Virus-mediated induction in human lymphocytes of antibody-independent cytotoxicity (VDCC) and enhancement of antibody-dependent cytotoxicity (ADCC) against natural killer-resistant tumor target cells. Alsheikhly AR; Andersson T; Perlmann P Cell Immunol; 1984 Oct; 88(2):511-20. PubMed ID: 6488328 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous development of antibody-dependent cellular cytotoxicity (ADCC) and natural killer (NK) activity in irradiated mice reconstituted with bone marrow cells. Sihvola M; Hurme M Cell Immunol; 1987 Oct; 109(1):115-22. PubMed ID: 3308121 [TBL] [Abstract][Full Text] [Related]
14. Augmentation of murine natural killer cell and antibody dependent cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator. Suresh K; Vasudevan DM J Ethnopharmacol; 1994 Aug; 44(1):55-60. PubMed ID: 7990505 [TBL] [Abstract][Full Text] [Related]
15. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine). Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674 [TBL] [Abstract][Full Text] [Related]
16. Potentiation of the efficacy of murine L1210 leukemia vaccine by a novel immunostimulator 7-thia-8-oxoguanosine: increased survival after immunization with vaccine plus 7-thia-8-oxoguanosine. Sharma BS; Balazs L; Jin A; Wang JC; Jolley WB; Robins RK Cancer Immunol Immunother; 1991; 33(2):109-14. PubMed ID: 2036658 [TBL] [Abstract][Full Text] [Related]
17. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686 [TBL] [Abstract][Full Text] [Related]
18. Severe suppression of the B-cell system has no impact on the maturation of natural killer cells in mice. Gidlund M; Ojo EA; Orn A; Wigzell H; Murgita RA Scand J Immunol; 1979; 9(2):167-73. PubMed ID: 311511 [TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor. Fuson EW; Cole AJ; Hubbard RA J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410 [TBL] [Abstract][Full Text] [Related]
20. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma. Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]